VistaGen Therapeutics, Inc.
VTGN
$0.61
-$0.02-3.73%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 61.77M | 77.18M | 63.18M | 80.48M | 88.56M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.48M | 1.76M | 3.54M | 1.59M | 1.38M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 63.25M | 78.93M | 66.72M | 82.08M | 89.94M |
|
|
|||||
| Total Current Assets | 63.25M | 78.93M | 66.72M | 82.08M | 89.94M |
| Net Property, Plant & Equipment | 1.42M | 1.59M | 1.74M | 1.81M | 1.89M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 392.00K | 405.00K | 472.00K | 454.00K | 477.00K |
| Total Assets | 65.06M | 80.93M | 68.92M | 84.34M | 92.31M |
|
|
|||||
| Total Accounts Payable | 1.28M | 1.83M | 486.00K | 653.00K | 1.04M |
| Total Accrued Expenses | 9.25M | 8.42M | 6.58M | 8.81M | 5.47M |
| Short-term Debt | 379.00K | 658.00K | 933.00K | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 617.00K | 597.00K | 640.00K | 561.00K | 603.00K |
| Total Finance Division Other Current Liabilities | 2.00M | 2.14M | 2.51M | 2.59M | 2.51M |
| Total Other Current Liabilities | 2.00M | 2.14M | 2.51M | 2.59M | 2.51M |
| Total Current Liabilities | 13.53M | 13.64M | 11.16M | 12.61M | 9.62M |
|
|
|||||
| Total Current Liabilities | 13.53M | 13.64M | 11.16M | 12.61M | 9.62M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 379.00K | 658.00K | 933.00K | -- | -- |
| Capital Leases | 431.00K | 610.00K | 783.00K | 948.00K | 1.11M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 176.00K | 336.00K | 221.00K | 391.00K | 454.00K |
| Total Liabilities | 14.14M | 14.59M | 12.16M | 13.95M | 11.19M |
|
|
|||||
| Common Stock & APIC | 515.92M | 512.44M | 483.46M | 481.99M | 479.08M |
| Retained Earnings | -461.04M | -442.14M | -422.73M | -407.63M | -394.00M |
| Treasury Stock & Other | -3.96M | -3.95M | -3.97M | -3.96M | -3.96M |
| Total Common Equity | 50.92M | 66.34M | 56.77M | 70.39M | 81.12M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 50.92M | 66.34M | 56.77M | 70.39M | 81.12M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 50.92M | 66.34M | 56.77M | 70.39M | 81.12M |
|
|
|||||